The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
|Articles|September 2, 2013
- Pharmaceutical Technology-09-02-2013
- Volume 37
- Issue 9
Pharmaceutical Technology, September 2013 Issue (PDF)
Click the title above to open the Pharmaceutical Technology September 2013 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 13 years ago
The Importance of Continued Investment in R&Dabout 13 years ago
FDA Works to Secure Drug Supply Chainabout 13 years ago
Outsourcing Partnerships for CMC Developmentabout 13 years ago
MF40 Automated Punch and Die Polishing Machineabout 13 years ago
Quality by Design in APIsabout 13 years ago
Connecting People, Science, and Regulationabout 13 years ago
Effective and Efficient Weighing of Potent Compoundsabout 13 years ago
EU Raises API Standards: A Curse in Disguise?about 13 years ago
The Importance of Characterization in Biosimilars Developmentabout 13 years ago
Omega Design Corporation Introduces LabelSync 450Advertisement
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why AI Model Updates Need Change Control: AAPS PharmSci 360 2026
2
From URS to Acceptance Evidence: Defining and Testing Interfaces in Pen Injector Assembly
3
USP 1074 Revises Excipient Safety: AAPS PharmSci 360 2026
4
AI Formulation: Regulators Want Data
5